{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:12:10Z","timestamp":1790694730796,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.contraception.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T01:46:57Z","timestamp":1339033617000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["RETIRED: Cancer and contraception"],"prefix":"10.1016","volume":"86","author":[{"given":"Ashlesha","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Bimla","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.05.008_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.contraception.2012.05.008_bb0010","series-title":"SEER cancer statistics review, 1975\u20132007","year":"2010"},{"key":"10.1016\/j.contraception.2012.05.008_bb0015","series-title":"Surveillance epidemiology and end results. Bethesda, MD","author":"(US) NIH","year":"2010"},{"issue":"2","key":"10.1016\/j.contraception.2012.05.008_bb0020","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1097\/01.NCC.0000305695.12873.d5","article-title":"Intimacy and sexuality after cancer: a critical review of the literature","volume":"31","author":"Hordern","year":"2008","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.contraception.2012.05.008_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5172\/conu.2007.27.1.49","article-title":"Let's talk about sex: risky business for cancer and palliative care clinicians","volume":"27","author":"Hordern","year":"2007","journal-title":"Contemp Nurse"},{"key":"10.1016\/j.contraception.2012.05.008_bb0030","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1586\/14737140.8.10.1589","article-title":"Management of reproductive needs in cancer patients: clinical perspectives","volume":"8","author":"Mitwally","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.contraception.2012.05.008_bb0035","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.ejca.2004.09.003","article-title":"Contraception for teenagers and young adults with cancer","volume":"40","author":"Laurence","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/mob.2002.126643","article-title":"Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"187","author":"Green","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djp064","article-title":"Induced abortions in Danish cancer survivors: a population-based cohort study","author":"Winther","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2012.05.008_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajog.2005.12.053","article-title":"Communicating contraceptive effectiveness: a randomized controlled trial to inform a World Health Organization family planning book","volume":"195","author":"Steiner","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0055","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1586\/14737140.7.7.989","article-title":"Fertility preservation and minimizing reproductive damage in cancer survivors","volume":"7","author":"Mitwally","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.contraception.2012.05.008_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.802","article-title":"Fertility among female Hodgkin's lymphoma survivors attempting pregnancy following ABVD chemotherapy","volume":"25","author":"Hodgson","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3816\/CBC.2008.n.004","article-title":"Fertility and menopausal outcomes in young breast cancer survivors","volume":"8","author":"Partridge","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198711193172104","article-title":"Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer","volume":"317","author":"Byrne","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1200\/JCO.2007.15.3130","article-title":"Reproduction rates after cancer treatment: experience from the Norwegian radium hospital","volume":"27","author":"Cvancarova","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0080","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.fertnstert.2005.03.013","article-title":"Fertility preservation and reproduction in cancer patients","volume":"83","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.05.008_bb0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1701-2163(16)30298-5","article-title":"Breast cancer, pregnancy, and breastfeeding","volume":"24","author":"Helewa","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2012.05.008_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jncimonographs\/lgi018","article-title":"Maintenance of ovarian function and risk of premature menopause related to cancer treatment","author":"Sklar","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.contraception.2012.05.008_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.05.008_bb0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.05.008_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/humupd\/dmh052","article-title":"Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing","volume":"11","author":"Lutchman Singh","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.05.008_bb0110","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","article-title":"The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.05.008_bb0115","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1128\/MCB.00012-10","article-title":"Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3","volume":"30","author":"Beguelin","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS steering and data monitoring committee. HABITS (hormonal replacement therapy after breast cancer \u2014 is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Stockholm Breast Cancer Study G. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2012.05.008_bb0130","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence","volume":"7","author":"Col","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.contraception.2012.05.008_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/17455057.4.2.151","article-title":"Progesterone and breast cancer","volume":"4","author":"Lange","year":"2008","journal-title":"Womens Health (London, England)"},{"key":"10.1016\/j.contraception.2012.05.008_bb0140","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/gme.0b013e3181d3dd0c","article-title":"Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice","volume":"17","author":"Liang","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.contraception.2012.05.008_bb0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/bcr539","article-title":"Progesterone receptors \u2014 animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer","volume":"4","author":"Lanari","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.contraception.2012.05.008_bb0150","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women","volume":"114","author":"Chan","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.05.008_bb0155","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13697130802163168","article-title":"Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen","volume":"11","author":"Kesim","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2012.05.008_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.05.008_bb0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system; long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0175","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.ejca.2006.08.020","article-title":"Continuous versus intermittent tamoxifen versus intermittent\/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC Phase III study (10863)","volume":"42","author":"Beex","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1006169012544","article-title":"Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group","volume":"55","author":"Kloke","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.contraception.2012.05.008_bb0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00187-1","article-title":"Post-marketing surveillance of Norplant((R)) contraceptive implants: II. Non-reproductive health(1)","volume":"63","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.contraception.2003.12.015","article-title":"Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer","volume":"69","author":"Strom","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0200","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1701-2163(16)32195-8","article-title":"Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint Review and Committee Opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada","volume":"28","author":"McNaught","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2012.05.008_bb0215","series-title":"Intrauterine devices in medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.contraception.2012.05.008_bb0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1160\/TH10-05-0277","article-title":"Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"104","author":"Di Nisio","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2012.05.008_bb0225","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2012.05.008_bb0230","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case\u2013control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0240","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0245","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0250","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2012.05.008_bb0255","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Early Release"},{"key":"10.1016\/j.contraception.2012.05.008_bb0260","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.05.008_bb0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","article-title":"Limited knowledge on progestogen-only contraception and risk of venous thromboembolism","volume":"88","author":"Bergendal","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.05.008_bb0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case\u2013control study","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.05.008_bb0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0290","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0295","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0300","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case\u2013control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2012.05.008_bb0305","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0310","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","article-title":"Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials","volume":"91","author":"Darney","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.05.008_bb0315","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0320","first-page":"262","article-title":"Effects of contraceptives on hemoglobin and ferritin","volume":"58","author":"Task Force for Epidemiological Research on Reproductive Health, United Nations Development Programme\/United Nations Population Fund\/World Health Organization\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0325","doi-asserted-by":"crossref","unstructured":"Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005:CD002126. Epub 2005\/10\/20 (Evidence Grade: I).","DOI":"10.1002\/14651858.CD002126.pub2"},{"key":"10.1016\/j.contraception.2012.05.008_bb0330","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/humrep\/del029","article-title":"Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen","volume":"21","author":"Hubacher","year":"2006","journal-title":"Hum Reprod"},{"issue":"6 Suppl","key":"10.1016\/j.contraception.2012.05.008_bb0335","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/S0010-7824(98)00123-1","article-title":"An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon","volume":"58","author":"Affandi","year":"1998","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.05.008_bb0340","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ctrv.2008.03.007","article-title":"Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group","volume":"34","author":"Reid","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.contraception.2012.05.008_bb0345","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer","volume":"30","author":"Ramaswamy","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0350","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2010.07.027","article-title":"The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age","volume":"83","author":"Gai","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0355","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1210\/jc.2010-0032","article-title":"Use of depot medroxyprogesterone acetate and fracture risk","volume":"95","author":"Meier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.05.008_bb0360","first-page":"CD006033","article-title":"Steroidal contraceptives: effect on bone fractures in women","volume":"95","author":"Lopez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.05.008_bb0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","article-title":"The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women","volume":"78","author":"Vestergaard","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0370","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.whi.2006.09.003","article-title":"Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities","volume":"16","author":"Watson","year":"2006","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2012.05.008_bb0375","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","article-title":"Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years","volume":"109","author":"Pongsatha","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4755-4-11","article-title":"A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants","volume":"4","author":"Monteiro-Dantas","year":"2007","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.008_bb0385","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.05.008_bb0390","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/humrep\/deq043","article-title":"Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system","volume":"25","author":"Bahamondes","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.05.008_bb0395","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.berh.2010.01.006","article-title":"Management of osteoporosis in a pre-menopausal woman","volume":"24","author":"Bhalla","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0400","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/eat.20687","article-title":"Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: a systematic review and meta-analyses","volume":"43","author":"Sim","year":"2010","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.contraception.2012.05.008_bb0405","first-page":"784","article-title":"Is the intrauterine device appropriate contraception for HIV-1-infected women?","volume":"108","author":"Morrison","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.05.008_bb0410","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(97)10319-1","article-title":"Complications of use of intrauterine devices among HIV-1-infected women","volume":"351","author":"Sinei","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0415","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.05.008_bb0420","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000363778.58203.b6","article-title":"Safety of hormonal and intrauterine methods of contraception for women with HIV\/AIDS: a systematic review","volume":"23","author":"Curtis","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2012.05.008_bb0425","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.contraception.2010.02.007","article-title":"Contraceptive use among solid organ transplant patients: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0435","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0440","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdl399","article-title":"Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors","volume":"18","author":"Sanna","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0445","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","article-title":"Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort","volume":"27","author":"Meadows","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0450","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-153-7-201010050-00007","article-title":"Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"153","author":"Nathan","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0455","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","article-title":"Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin's lymphoma","volume":"110","author":"Hodgson","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41","author":"Xiao","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0465","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0015-0282(16)49397-0","article-title":"Sustained intrauterine release of levonorgestrel over five years","volume":"45","author":"Nilsson","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.05.008_bb0470","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.05.008_bb0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10552-008-9213-y","article-title":"Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai","volume":"20","author":"Rosenblatt","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2012.05.008_bb0480","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.contraception.2012.05.008_bb0485","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.contraception.2010.04.006","article-title":"Factors affecting mortality in a large cohort study with special reference to oral contraceptive use","volume":"82","author":"Vessey","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0490","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/01.AOG.0000284446.22251.6e","article-title":"Oral contraceptives and the risk of death from breast cancer","volume":"110","author":"Wingo","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0495","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1158\/1055-9965.EPI-11-0022","article-title":"Oral contraceptive use and survival in women with invasive breast cancer","volume":"20","author":"Lu","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2012.05.008_bb0500","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.bjc.6601715","article-title":"Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian\u2013Swedish Women's Lifestyle and Health Cohort Study","volume":"90","author":"Kumle","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0505","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.contraception.2012.05.008_bb0510","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","article-title":"Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition","volume":"127","author":"Dossus","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0515","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer","volume":"28","author":"Kim","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.contraception.2012.05.008_bb0520","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the levonorgestrel-releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6 Suppl","key":"10.1016\/j.contraception.2012.05.008_bb0525","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.contraception.2007.01.002","article-title":"Neoplasia with use of intrauterine devices","volume":"75","author":"Curtis","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0530","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.annepidem.2010.10.002","article-title":"Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer","volume":"21","author":"Ness","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0535","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.05.008_bb0540","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ijc.24232","article-title":"Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006","volume":"124","author":"Dorjgochoo","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0545","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.contraception.2010.02.013","article-title":"Intrauterine device use among women with ovarian cancer: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.008_bb0550","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis","volume":"46","author":"Iodice","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.contraception.2012.05.008_bb0555","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/09513590.2010.487609","article-title":"Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy","volume":"26","author":"Gadducci","year":"2010","journal-title":"Gynecol Endocrinol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:58Z","timestamp":1761432298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0010782412002533"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.05.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETIRED: Cancer and contraception","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}